Aquablation therapy - the BPH treatment of choice for all prostates.
San Jose, California
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS™ Robotic Systems. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy. The HYDROS Robotic System is currently cleared for use in the United States only.
On-site · Vancouver
Develop and manage the commercial operating model for the peer-to-peer ecosystem, focusing on KOL segmentation, onboarding, and activation. Establish the infrastructure for tracking engagement and ROI while scaling real-world evidence and best practices to drive product adoption.
